108 related articles for article (PubMed ID: 17649816)
1. Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients.
Richter C; Baetje M; Bischof A; Makovitzky J; Richter DU; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2023-5. PubMed ID: 17649816
[TBL] [Abstract][Full Text] [Related]
2. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.
Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K
Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409
[TBL] [Abstract][Full Text] [Related]
3. Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
Tsviliana A; Mayr D; Kuhn C; Kunze S; Mylonas I; Jeschke U; Friese K
Anticancer Res; 2010 May; 30(5):1637-40. PubMed ID: 20592354
[TBL] [Abstract][Full Text] [Related]
4. Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer.
Bischof A; Briese V; Richter DU; Bergemann C; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1639-44. PubMed ID: 16033074
[TBL] [Abstract][Full Text] [Related]
5. Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R
Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812
[TBL] [Abstract][Full Text] [Related]
6. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract][Full Text] [Related]
7. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
[TBL] [Abstract][Full Text] [Related]
8. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties.
Kämäräinen M; Leivo I; Koistinen R; Julkunen M; Karvonen U; Rutanen EM; Seppälä M
Am J Pathol; 1996 May; 148(5):1435-43. PubMed ID: 8623915
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma.
Kunert-Keil C; Steinmüller F; Jeschke U; Gredes T; Gedrange T
Acta Histochem; 2011 Dec; 113(8):798-802. PubMed ID: 21168900
[TBL] [Abstract][Full Text] [Related]
10. Glycodelin A and differentiation of first trimester trophoblast cells in vitro.
Jeschke U; Richter DU; Reimer T; Bergemann C; Briese V; Karsten U; Mylonas I; Kupka MS; Wiest I; Friese K
Arch Gynecol Obstet; 2005 Jul; 272(2):151-9. PubMed ID: 15549334
[TBL] [Abstract][Full Text] [Related]
11. Increased glycodelin levels in gynecological malignancies.
Horowitz IR; Cho C; Song M; Flowers LC; Santanam N; Parthasarathy S; Ramachandran S
Int J Gynecol Cancer; 2001; 11(3):173-9. PubMed ID: 11437921
[TBL] [Abstract][Full Text] [Related]
12. Glycodelin: a reproduction-related lipocalin.
Halttunen M; Kämäräinen M; Koistinen H
Biochim Biophys Acta; 2000 Oct; 1482(1-2):149-56. PubMed ID: 11058757
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues.
Jeschke U; Kuhn C; Mylonas I; Schulze S; Friese K; Mayr D; Speer R; Briese V; Richter DU; Haase M; Karsten U
Histopathology; 2006 Mar; 48(4):394-406. PubMed ID: 16487361
[TBL] [Abstract][Full Text] [Related]
14. Expression of glycodelin in human breast and breast cancer.
Kämäräinen M; Halttunen M; Koistinen R; von Boguslawsky K; von Smitten K; Andersson LC; Seppälä M
Int J Cancer; 1999 Dec; 83(6):738-42. PubMed ID: 10597188
[TBL] [Abstract][Full Text] [Related]
15. Expression of placental protein 14 by the new endometrial cancer cell line MFE-280 in vitro and by endometrial carcinomas in vivo.
Hackenberg R; Loos S; Nia AH; Kunzmann R; Schulz KD
Anticancer Res; 1998; 18(2A):1153-8. PubMed ID: 9615781
[TBL] [Abstract][Full Text] [Related]
16. Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells.
Koistinen H; Seppälä M; Nagy B; Tapper J; Knuutila S; Koistinen R
Am J Obstet Gynecol; 2005 Dec; 193(6):1955-60. PubMed ID: 16325596
[TBL] [Abstract][Full Text] [Related]
17. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
Jeschke U; Bischof A; Speer R; Briese V; Richter DU; Bergemann C; Mylonas I; Shabani N; Friese K; Karsten U
Anticancer Res; 2005; 25(3A):1581-9. PubMed ID: 16033064
[TBL] [Abstract][Full Text] [Related]
18. Expression of endometrial protein PP14 in pelvic and ovarian endometriotic implants.
Cornillie FJ; Lauweryns JM; Seppälä M; Riittinen L; Koninckx PR
Hum Reprod; 1991 Nov; 6(10):1411-5. PubMed ID: 1770137
[TBL] [Abstract][Full Text] [Related]
19. [Is glycodelin an important marker of endometrial receptivity?].
Skrzypczak J; Wirstlein P; Mikołajczyk M
Ginekol Pol; 2005 Oct; 76(10):770-81. PubMed ID: 16417092
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and fate of glycodelin in human ovary during folliculogenesis.
Tse JY; Chiu PC; Lee KF; Seppala M; Koistinen H; Koistinen R; Yao YQ; Yeung WS
Mol Hum Reprod; 2002 Feb; 8(2):142-8. PubMed ID: 11818517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
